Biosynex SA (ALBIO) Price & Analysis

2 Followers

ALBIO Stock Chart & Stats

€0.86

€0.10(4.52%)

At close: Jan 09 4:00 PM EST

€0.86

€0.10(4.52%)

Day’s Range― - ―

52-Week Range€0.46 - €1.57

Previous CloseN/A

Volume2.82K

Average Volume (3M)61.22K

Market Cap

€16.37M

Enterprise Value€70.41M

Total Cash (Recent Filing)€8.46M

Total Debt (Recent Filing)€61.65M

Price to Earnings (P/E)―

Beta-0.02

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-4.26

Shares Outstanding18,748,032

10 Day Avg. Volume39,959

30 Day Avg. Volume61,221

Financial Highlights & Ratios

PEG Ratio0.03

Price to Book (P/B)0.34

Price to Sales (P/S)0.12

P/FCF Ratio-1.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Biosynex SA News

BIOSYNEX SA Announces Share and Voting Rights Update

Biosynex SA ( ($FR:ALBIO) ) has provided an update. BIOSYNEX SA announced the number of shares and voting...

1y ago

Biosynex SA Secures 7.99 Million Euros in Capital Increase

Biosynex SA ( ($FR:ALBIO) ) has issued an update. Biosynex SA successfully completed a capital increase, securing gross...

1y ago

Biosynex SA Announces Capital Increase to Strengthen Financial Stability

Biosynex SA ( ($FR:ALBIO) ) has shared an announcement. Biosynex SA has announced a capital increase with the...

1y ago

Biosynex SA Reports Revenue Growth and Restructures for Future Stability

Biosynex SA ( ($FR:ALBIO) ) has shared an update. Biosynex SA reported a 9% increase in revenue for...

1y ago

Biosynex SA Unveils 2025 Financial Calendar

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA, a leading health diagnostics group, has announced its 2025...

2y ago

Biosynex SA Restructures Debt and Plans Capital Increase

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA has reached an agreement with its main creditors to...

2y ago

Biosynex SA Expands Global Reach in Diagnostics

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA, a leader in health diagnostics, reported a turnover of...

2y ago

Biosynex Secures Grant for Syphilis Diagnostic Test

Biosynex SA (FR:ALBIO) has released an update. Biosynex’s subsidiary, Chembio Diagnostics, has received a $1.5 million grant from...

2y ago

Biosynex SA Reports Robust Growth Amid Financial Restructuring

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA reported a strong revenue growth of 26% in the...

2y ago

Biosynex SA Sees Strong H1 2024 Revenue Growth

Biosynex SA (FR:ALBIO) has released an update. Biosynex SA reported a 26% increase in H1 2024 revenue to...

2y ago

ALBIO FAQ

What was Biosynex SA’s price range in the past 12 months?

Biosynex SA lowest stock price was €0.46 and its highest was €1.57 in the past 12 months.

What is Biosynex SA’s market cap?

Biosynex SA’s market cap is €16.37M.

When is Biosynex SA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Biosynex SA’s earnings last quarter?

Currently, no data Available

Is Biosynex SA overvalued?

According to Wall Street analysts Biosynex SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biosynex SA pay dividends?

Biosynex SA pays a Annually dividend of €2 which represents an annual dividend yield of N/A. See more information on Biosynex SA dividends here

What is Biosynex SA’s EPS estimate?

Biosynex SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biosynex SA have?

Biosynex SA has 18,748,032 shares outstanding.

What happened to Biosynex SA’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Biosynex SA?

Currently, no hedge funds are holding shares in FR:ALBIO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Biosynex SA

Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.